About
Personalized Cancer Vaccines
Areas of Focus
Categories
VaccineSouthwestern U.S.
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
276
By Phase
PHASE2: 2PHASE1/PHASE2: 1
By Status
COMPLETED: 2TERMINATED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06175221Lead Sponsor
Autologous TLPO Vaccine Basket
PHASE2Terminated
63 participants
Started: Nov 29, 2023 · Completed: Jul 2, 2025
NCT02678741Lead Sponsor
Multi-center Phase I/IIa Trial of an Autologous Tumor Lysate (TL) + Yeast Cell Wall Particles (YCWP) + Dendritic Cells (DC) Vaccine in Addition to Standard of Care Checkpoint Inhibitor of Choice in Metastatic Melanoma Patients With Measurable Disease.
PHASE1/PHASE2Completed
26 participants
Started: Feb 29, 2016 · Completed: Nov 13, 2019
NCT02301611Lead Sponsor
Phase IIB TL + YCWP + DC in Melanoma
PHASE2Completed
187 participants
Started: Jan 31, 2015 · Completed: May 11, 2022
Locations (1)
Headquarters
Austin, TX, United States
Map
Loading map...